THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
AROUND THE REGION

FDA approves Covidien clot therapy

Associated Press / November 5, 2010

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

MANSFIELD — Covidien said yesterday the Food and Drug Administration has approved its Kendall Sequential Compression Comfort Sleeve and Kendall SCD 700 Series Controller for the treatment of deadly blood clots in the arms and legs known as deep vein thrombosis.

The new system will be launched next month in the United States. The company said the compression technology reduces the incidence of potentially fatal blood clots in deep veins and their travel to the lung’s arteries without the bleeding risk associated with taking blood thinners.